Periostat Articles
HalcyGen to buy fellow Australian drugmaker Mayne Pharma for $15 million
25 September 2009
Warner Chilcott gets FDA response to citizens petition
23 March 2009
Patent suit filed in USA over Doryx generic
12 January 2009
New Warner Chilcott posts 1st-qtr loss
11 July 2005
IVAX gets approval for doxycycline
23 May 2005
Alliance swings to loss for first half, reports acquisitions
1 November 2004
Warner Chilcott beats expectations
16 August 2004
Promising new data for CollaGenex' Periostat
23 February 2004
Galen reports 105% leap in 1st-qtr sales
16 February 2004
Stock Commentary - Europe
26 May 2003
Galen's profits grow as sales rocket 57%
19 May 2003
Galen EPS leaps 35%, beating forecasts
17 February 2003
CollaGenex drug starts pivotal trial in rosacea
19 August 2002
Periostat cleared for marketing in Israel
13 May 2002
CollaGenex revenues up 53% in first quarter
29 April 2002
CollaGenex revenues rise 45%
18 February 2002
Pharma DTC web sites failing to address consumer needs, says study
14 September 2001
Atridox cleared in Switzerland
5 July 2001
Atridox cleared in three European countries
10 May 2001
Galen 2nd-qtr profits and revenues soar
2 May 2001
OraPharma's Arestin approved in USA
19 February 2001
New Periostat formulation cleared in USA
8 February 2001
UK approves PerioStat
2 March 2000
Atrix Labs gets European backing for Atridox
11 January 2000
Atrix Labs gets European backing for Atridox
11 January 2000
Atrix strategy change?
16 September 1999
Atrix poised for long-term growth in drug delivery
16 July 1999
First Euro approval for Atrix' Atridox
29 April 1999
Atrix' Atridox Now Available In USA
26 November 1998
CollaGenex files for Periostat in UK
5 November 1998
First Oral Periodontitis Treatment In USA
8 October 1998
US Launch Of Atridox For Periodontitis
18 September 1998
Milestone Payment For Atrix On Atridox/Atrigel Approval
18 September 1998
Loss Per Share Narrows At Warner Chilcott
8 May 1998
Atrix' Dental Product Approvable In USA
15 April 1998
FDA Regulatory News In Brief
4 February 1998
Atrix Submits Atridox Dossier To MCA
16 October 1997
Periostat Filed In First European Market
24 July 1997
Atridox Filing Accepted In USA
12 June 1997
Atrix Submits NDA For Atridox
21 April 1997
Atrix Advances In Periodontal Disease
7 April 1997
Atrix' $50M Alliance With Block Drug
13 January 1997
FDA Accepts Filing Of Collagenex Pharmaceuticals' Periostat
2 December 1996
Good Clinical Trial Results For Atrix' Periodontal Product
9 September 1996
Showing 1-48 of 48 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
